MF Lee,1 CW Chang,2
NM Wang,2 SJ Lin,3 YH Chen4,5 |
1Department of Medical
Research, Taichung Veterans General Hospital, and
General Education Center, Tunghai University, Taichung,
Taiwan
2Institute of Biotechnology, National
Changhua University of Education, Changhua, Taiwan
3School of Medical Laboratory and
Biotechnology, Chung Shan Medical University, Taichung,
Taiwan
4Division of Allergy, Immunology and
Rheumatology, Taichung Veterans General Hospital,
Taichung, Taiwan
5Faculty of Medicine, National Yang-Ming
University, Taipei, Taiwan |
Abstract |
Background and
objective:
Allergic airway
diseases are not
only a TH2-mediated
chronic airway
inflammation, but
also a condition of
epithelial barrier
defects and
dysfunction.
Allergens with
protease activities
are known factors
that initiate
respiratory
epithelial damage.
Cockroach allergy is
the second leading
cause of allergic
respiratory airway
diseases in Taiwan,
and cockroach
allergens have
strong serine
protease activity.
This study aimed to
determine the
protective effect of
the direct local
administration of
gabexate mesilate
(GM) on American
cockroach allergen (CraA)induced
human bronchial
epithelial cell
inflammation.
Methods:
BEAS-2B cells, from
the human bronchial
epithelial cell
line, were
stimulated with CraA
or co-cultured with
different doses of
GM. Cellular
morphologic changes
were observed by
microscopy and
changes in chemokine
mRNA expression and
protein levels were
determined by
semi-quantitative
reverse
transcriptionpolymerase
chain reaction (RT-PCR)
and ELISA. Effects
of specific
inhibitors of ERK1/2
(U0126), JNK
(SP600125), and p38
MAPK (SB203580) on
CraA-induced
chemokine mRNA
expression were also
tested by RT-PCR.
Results: GM
prevented CraA-induced
bronchial epithelial
cell detachment and
morphological
changes. It had
superior and more
extensive
suppression effects
than specific target
MAPK inhibitors in
CraA-induced mRNA
expression of IL-8,
monocyte chemotactic
protein (MCP) 1,
chemokine (C-C
motif) ligand 20,
and
granulocyte-macrophage
colony-stimulating
factor from the
cells in a
dose-dependent
manner. CraA-induced
IL-8 and MCP-1
protein production
from BEAS-2B cells
was also attenuated
by GM.
Conclusions:
The serine protease
inhibitor GM has
local protective
effects against CraA-induced
bronchial epithelial
inflammation. The
development of an
inhaled or
intranasal protease
inhibitor may be a
potential strategy
for the treatment of
allergic airway
diseases induced by
allergens with
protease activities.
Key words:
Cockroach allergy.
Bronchial epithelial
cells. Serine
protease inhibitor.
Gabexate mesilate. |
|
|
|
|
|
|